Clinical efficacy and pharmacokinetics of 1% ropivacaine and 0.75% bupivacaine in peribulbar anaesthesia for cataract surgery

Anaesthesia

Volumn 54, Issue 2, 1999, Pages 137-141

  Huha, T ^a   Ala Kokko, T I ^a   Salomaki T ^a   Alahuhta, S ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Anaesthesia; ophthalmic; Anaesthetics; local, bupivacaine, ropivacaine

Indexed keywords

BUPIVACAINE; HYALURONIDASE; LOCAL ANESTHETIC AGENT; ROPIVACAINE;

AGED; AKINESIA; ANALGESIA; AREA UNDER THE CURVE; ARTICLE; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EYELID; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIBULBAR ANESTHESIA; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; AMIDES; ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; BUPIVACAINE; CATARACT EXTRACTION; DOUBLE-BLIND METHOD; EYE MOVEMENTS; EYELIDS; FEMALE; HUMANS; MALE; MOVEMENT; PROSPECTIVE STUDIES;

EID: 0032931082     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.1999.00668.x     Document Type: Article

References (25)

1. Hamilton RC, Gimbel HV, Strunin L. Regional anaesthesia for 12,000 cataract extraction and intraocular lens implantation procedures. Canadian Journal of Anaesthesia 1988; 35: 615-23.
2. Davis BD, Mandel MR. Efficacy and complication rate of 16,224 consecutive peribulbar blocks. A prospective multicenter study. Journal of Cataract and Refractive Surgery 1994; 20: 327-37.
3. McClure JH. Ropivacaine. British Journal of Anaesthesia 1996; 76: 300-7.
4. Knudsen K, Beckman Suurkula M, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. British Journal of Anaesthesia 1997; 78: 507-14.
5. Markham A, Faulds D. Ropivacaine: a review of its pharmacology and therapeutic use in regional anaesthesia. Drugs 1996; 52: 429-49.
6. Morsman CD, Holden R. The effects of adrenaline, hyaluronidase and age on peribulbar anaesthesia. Eye 1992; 6: 290-2.
7. Roberts JE, MacLeod BA, Hollands RH. Improved peribulbar anesthesia with alkalinization and hyaluronidase. Canadian Journal of Anaesthesia 1993; 40: 835-8.
8. Sarvela PJ, Nikki P. Hyaluronidase improves regional ophthalmic anaesthesia with etidocaine. Canadian Journal of Anaesthesia 1992; 39: 920-4.
9. Hamilton RC. Techniques of orbital regional anaesthesia. British Journal of Anaesthesia 1995; 75: 88-92.
10. Sarvela J, Nikki P, Paloheimo M. Orbicular muscle akinesia in regional ophthalmic anaesthesia with pH-adjusted bupivacaine: effects of hyaluronidase and epinephrine. Canadian Journal of Anaesthesia 1993; 40: 1028-33.
11. Ala-Kokko TI, Alahuhta S, Arvela P, Vähäkangas K. Maternal, fetal and placental distribution of lidocaine-epinephrine and bupivacaine after epidural administration for cesarean section. International Journal of Obstetric Anesthesia 1998; 7: 82-7.
12. Gardner MJ, Altman DG. Statistic with confidence: confidence intervals and statistical guidelines. British Medical Journal 1990; 29-30.
13. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. British Medical Journal 1990; 300: 230-5.
14. Zaric D, Nydahl B-A, Philipson L, Samuelsson L, Heierson A, Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers. A double blind study. Regional Anaesthesia 1996; 21: 14-25.
15. Sarvela P. Comparison of regional ophthalmic anesthesia produced by pH-adjusted 0.75% and 0.5% bupivacaine and 1% and 1.5% etidocaine, all with hyaluronidase. Anesthesia and Analgesia 1993; 77: 131-4.
16. Wood MB, Rubin AP. A comparison of epidural 1% ropivacaine and 0.75% bupivacaine for lower abdominal gynecologic surgery. Anesthesia and Analgesia 1993; 76: 1274-8.
17. Brockway MS, Bannister J, McClure JH, McKeown D, Wildsmith JAW. Comparison of extradural ropivacaine and bupivacaine. British Journal of Anaesthesia 1991; 66: 31-7.
18. Emanuelsson B-M, Persson J, Sandin S, Alm C, Gustafsson LL. Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects. Therapeutic Drug Monitoring 1997; 19: 126-31.
19. Barr J, Kirkpatric N, Dick A, Leonard L, Hawksworth G, Noble DW. Effects of adrenaline and hyaluronidase on plasma concentrations of lignocaine and bupivacaine after peribulbar anaesthesia. British Journal of Anaesthesia 1995; 75: 692-7.
20. Gao F, Budd AJ. Venous levels of lignocaine and bupivacaine after peribulbar block. Anaesthesia 1996; 51: 1109-12.
21. Kallio H, Puska P, Summanen P, Paloheimo M, Maunuksela E-L. Ropivacaine and lignocaine in parabulbar block for cyclophotocoagulation with krypton or diode laser or retinal panphotocoagulation with argon laser. International Monitor on Regional Anaesthesia 1997; 9: 92.
22. Rosenberg PH, Kyttä J, Alila A. Absorption of bupivacaine, etidocaine, lignocaine and ropivacaine into n-heptane, rat sciatic nerve, and human extradural and subcutaneous fat. British Journal of Anaesthesia 1986; 58: 310-4.
23. Lee A, Fagan D, Lamont M, Tucker GT, Haldin M, Scott DB. Disposition kinetics of ropivacaine in humans. Anesthesia and Analgesia 1989; 69: 736-8.
24. Ala-Kokko TI, Alahuhta S, Jouppila P, Korpi K, Westerling P, Vähäkangas K. Feto-maternal distribution of ropivacaine and bupivacaine after epidural administration for cesarean section. International Journal of Obstetric Anesthesia 1997; 6: 147-52.
25. Morrison LMN, Emanuelsson BM, McClure JH et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. British Journal of Anaesthesia 1994; 72: 164-9.